or Try an Advanced Search...

    Technical Analysis for STOK - Stoke Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 11.57 2.30% 0.26
    STOK closed down 2.58 percent on Wednesday, November 20, 2024, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical STOK trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 2.30%
    Down 3 Days in a Row Weakness 2.30%
    Down 4 Days in a Row Weakness 2.30%
    Lower Bollinger Band Touch Weakness 2.30%
    Oversold Stochastic Weakness 2.30%
    MACD Bearish Centerline Cross Bearish -0.34%
    Stochastic Reached Oversold Weakness -0.34%
    Down 3 Days in a Row Weakness -0.34%
    Lower Bollinger Band Touch Weakness -0.34%
    Oversold Stochastic Weakness -0.34%
    Older End-of-Day Signals for STOK ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 14 minutes ago
    Up 1% about 1 hour ago
    60 Minute Opening Range Breakout about 1 hour ago
    Lower Bollinger Band Support about 2 hours ago
    Down 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    STOK Chart by TradingView
    Basic chart:

    Profile

    Stoke Therapeutics is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Precision Medicine Genetic Diseases Proteins Epigenetics Severe Genetic Diseases

    Is STOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
    Nov 8 Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade
    Nov 6 Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues
    Nov 5 Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates
    Nov 5 Stoke Therapeutics GAAP EPS of -$0.47 beats by $0.06, revenue of $4.89M beats by $1.29M
    Nov 5 Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
    Nov 1 Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
    Oct 29 Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
    Oct 12 Stoke Therapeutics assumed with an Outperform at Leerink
    Oct 12 Stoke Therapeutics, Inc (STOK): Pioneering RNA Medicine for Genetic Diseases
    See more STOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.58
    52 Week Low 3.77
    Average Volume 591,691
    200-Day Moving Average 12.33
    50-Day Moving Average 12.84
    20-Day Moving Average 12.75
    10-Day Moving Average 12.92
    Average True Range 0.72
    RSI (14) 33.77
    ADX 19.69
    +DI 21.78
    -DI 32.02
    Chandelier Exit (Long, 3 ATRs) 12.55
    Chandelier Exit (Short, 3 ATRs) 13.25
    Upper Bollinger Bands 14.36
    Lower Bollinger Band 11.14
    Percent B (%b) 0.05
    BandWidth 25.26
    MACD Line -0.18
    MACD Signal Line 0.02
    MACD Histogram -0.2035
    Fundamentals Value
    Market Cap 505.03 Million
    Num Shares 44.7 Million
    EPS -2.43
    Price-to-Earnings (P/E) Ratio -4.65
    Price-to-Sales 22.55
    Price-to-Book 1.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.14
    Resistance 3 (R3) 12.16 11.90 12.00
    Resistance 2 (R2) 11.90 11.68 11.89 11.96
    Resistance 1 (R1) 11.60 11.55 11.47 11.59 11.91
    Pivot Point 11.34 11.34 11.28 11.33 11.34
    Support 1 (S1) 11.05 11.13 10.92 11.03 10.71
    Support 2 (S2) 10.79 11.00 10.78 10.66
    Support 3 (S3) 10.49 10.79 10.62
    Support 4 (S4) 10.48